These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 28067896)
1. Pathogenic role of endogenous TNF-α in the development of Sjögren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice. Zhou J; Kawai T; Yu Q Lab Invest; 2017 Apr; 97(4):458-467. PubMed ID: 28067896 [TBL] [Abstract][Full Text] [Related]
3. Disruption of CXCR3 function impedes the development of Sjögren's syndrome-like xerostomia in non-obese diabetic mice. Zhou J; Yu Q Lab Invest; 2018 May; 98(5):620-628. PubMed ID: 29348563 [TBL] [Abstract][Full Text] [Related]
4. Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjögren's Syndrome Model Mice. Kurosawa M; Shikama Y; Furukawa M; Arakaki R; Ishimaru N; Matsushita K Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669065 [TBL] [Abstract][Full Text] [Related]
6. Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice. Zhou J; Jin JO; Kawai T; Yu Q Sci Rep; 2016 Dec; 6():39105. PubMed ID: 27966604 [TBL] [Abstract][Full Text] [Related]
7. Total glucosides of paeony (TGP) alleviates Sjogren's syndrome through inhibiting inflammatory responses in mice. Li B; Liu G; Liu R; He S; Li X; Huang L; Wang Z; Li Y; Chen Y; Yin H; Fang W Phytomedicine; 2020 Jun; 71():153203. PubMed ID: 32402913 [TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome. Hauk V; Calafat M; Larocca L; Fraccaroli L; Grasso E; Ramhorst R; Leirós CP Clin Exp Immunol; 2011 Dec; 166(3):309-16. PubMed ID: 22059987 [TBL] [Abstract][Full Text] [Related]
9. Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction. Sharma A; Kiripolsky J; Klimatcheva E; Howell A; Fereidouni F; Levenson R; Rothstein TL; Kramer JM Clin Immunol; 2016 Mar; 164():85-94. PubMed ID: 26826598 [TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide inhibits TNF-alpha-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands. Calafat M; Larocca L; Roca V; Hauk V; Pregi N; Nesse A; Pérez Leirós C Arthritis Res Ther; 2009; 11(2):R53. PubMed ID: 19356238 [TBL] [Abstract][Full Text] [Related]
11. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome. Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682 [TBL] [Abstract][Full Text] [Related]
12. Alternate-Day Fasting Ameliorates Newly Established Sjögren's Syndrome-like Sialadenitis in Non-Obese Diabetic Mice. Li D; Onodera S; Deng S; Alnujaydi B; Yu Q; Zhou J Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430269 [TBL] [Abstract][Full Text] [Related]
13. Syndecan-1 Plays a Role in the Pathogenesis of Sjögren's Disease by Inducing B-Cell Chemotaxis through CXCL13-Heparan Sulfate Interaction. Lee NY; Ture HY; Lee EJ; Jang JA; Kim G; Nam EJ Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273320 [TBL] [Abstract][Full Text] [Related]
14. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice. Gatumu MK; Skarstein K; Papandile A; Browning JL; Fava RA; Bolstad AI Arthritis Res Ther; 2009; 11(1):R24. PubMed ID: 19222863 [TBL] [Abstract][Full Text] [Related]
15. P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome. Schrader AM; Camden JM; Weisman GA Arch Oral Biol; 2005 Jun; 50(6):533-40. PubMed ID: 15848146 [TBL] [Abstract][Full Text] [Related]
16. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease. Peck AB; Nguyen CQ; Ambrus J Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965 [TBL] [Abstract][Full Text] [Related]
17. Myd88 is required for disease development in a primary Sjögren's syndrome mouse model. Kiripolsky J; McCabe LG; Gaile DP; Kramer JM J Leukoc Biol; 2017 Dec; 102(6):1411-1420. PubMed ID: 28951424 [TBL] [Abstract][Full Text] [Related]
18. Agonist-induced 4-1BB activation prevents the development of Sjӧgren's syndrome-like sialadenitis in non-obese diabetic mice. Zhou J; You BR; Yu Q Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165605. PubMed ID: 31740402 [TBL] [Abstract][Full Text] [Related]
19. Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome. Wieczorek G; Bigaud M; Pfister S; Ceci M; McMichael K; Afatsawo C; Hamburger M; Texier C; Henry M; Cojean C; Erard M; Mamber N; Rush JS Ann Rheum Dis; 2019 Jul; 78(7):974-978. PubMed ID: 30902822 [TBL] [Abstract][Full Text] [Related]
20. Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy. Soyfoo MS; De Vriese C; Debaix H; Martin-Martinez MD; Mathieu C; Devuyst O; Steinfeld SD; Delporte C Arthritis Rheum; 2007 Aug; 56(8):2566-74. PubMed ID: 17665453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]